Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 3
1962 1
1963 6
1964 59
1965 1172
1966 1547
1967 1658
1968 1916
1969 2073
1970 2210
1971 2204
1972 2562
1973 2937
1974 3269
1975 3827
1976 4128
1977 4107
1978 4528
1979 4390
1980 4373
1981 4917
1982 5342
1983 6125
1984 6252
1985 7101
1986 7829
1987 8361
1988 8807
1989 10541
1990 11727
1991 12068
1992 12027
1993 12558
1994 18843
1995 20535
1996 19769
1997 21385
1998 21859
1999 23501
2000 22467
2001 21380
2002 22008
2003 25138
2004 27901
2005 30617
2006 30087
2007 31276
2008 30661
2009 31451
2010 33517
2011 37888
2012 41814
2013 49333
2014 54699
2015 57047
2016 54655
2017 55102
2018 56413
2019 43822
2020 4924
Text availability
Article attribute
Article type
Publication date

Search Results

950,732 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry.
Hosokawa Y, Kawakita R, Yokoya S, Ogata T, Ozono K, Arisaka O, Hasegawa Y, Kusuda S, Masue M, Nishibori H, Sairenchi T, Yorifuji T. Hosokawa Y, et al. Endocr J. 2017 Sep 30;64(9):867-880. doi: 10.1507/endocrj.EJ17-0024. Epub 2017 Jul 11. Endocr J. 2017. PMID: 28701683 Free article. Clinical Trial.
Hyperferritinemia: causes and significance in a general hospital.
Senjo H, Higuchi T, Okada S, Takahashi O. Senjo H, et al. Hematology. 2018 Dec;23(10):817-822. doi: 10.1080/10245332.2018.1488569. Epub 2018 Jun 19. Hematology. 2018. PMID: 29914346 Clinical Trial.
Poison ivy: How effective are available treatments?
Vaught CK, Mold JW. Vaught CK, et al. J Fam Pract. 2016 Nov;65(11):801-809. J Fam Pract. 2016. PMID: 28087871 Clinical Trial.
Efficacy of risk stratification protocols and clinical, physical, and biochemical parameters to previse signals and symptoms during cardiovascular rehabilitation programs: Protocol for an observational trial.
Vanzella LM, Takahashi C, Ribeiro F, Lima IM, Silva AKFD, Christófaro DGD, Vanderlei LCM. Vanzella LM, et al. Medicine (Baltimore). 2019 Jun;98(24):e15700. doi: 10.1097/MD.0000000000015700. Medicine (Baltimore). 2019. PMID: 31192910 Free PMC article. Clinical Trial.
950,732 results
Jump to page
Feedback